BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.06%
This Quarter Est. Return
1 Year Est. Return
+15.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.15B
AUM Growth
-$535M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
31
New
Increased
Reduced
Closed

Top Buys

1
+$40.2M
2
+$34.8M
3
+$28.5M
4
RDUS
Radius Health, Inc.
RDUS
+$24.3M
5
KITE
Kite Pharma, Inc.
KITE
+$22.3M

Top Sells

1
+$126M
2
+$5.99M
3
+$4.68M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$1.99M
5
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$187K

Sector Composition

1 Healthcare 83.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$414M 13.12%
3,750,406
+10,000
2
$388M 12.31%
3,589,298
+25,000
3
$296M 9.39%
4,272,140
+350,000
4
$272M 8.64%
2,774,596
+59,000
5
$268M 8.5%
6,634,838
+705,412
6
$162M 5.13%
1,034,428
+257,000
7
$149M 4.72%
2,109,921
+120,000
8
$142M 4.51%
1,365,445
+31,000
9
$126M 4%
3,171,552
-50,000
10
$110M 3.48%
2,581,112
11
$95.4M 3.02%
205,000
+7,000
12
$93.1M 2.95%
6,929,832
+852,664
13
$91M 2.89%
1,132,499
+167,000
14
$58.9M 1.87%
416,500
+7,500
15
$56.8M 1.8%
618,188
16
$53.1M 1.68%
1,305,000
+855,000
17
$52.7M 1.67%
1,891,900
+125,000
18
$49.5M 1.57%
1,510,150
+355,000
19
$46.3M 1.47%
1,154,582
+250,000
20
$41.8M 1.32%
750,000
+400,000
21
$39.3M 1.25%
521,991
22
$35M 1.11%
210,719
+30,000
23
$34.8M 1.1%
1,302,912
+50,000
24
$22.8M 0.72%
2,700,737
25
$21.4M 0.68%
+908,542
1
2